1) Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003:an evidence based approach to the management of knee osteoarthritis:Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55.
2) Jørgensen A, Stengaard-Pedersen K, Simonsen O, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis:a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 2010;69:1097-102.
3) Lohmander LS, Dalén N, Englund G, et al. Intra-articular hyaluronan injections in the treatment ofosteoarthritis of the knee:a randomised, doubleblind, placebo controlled multicentretrial. Ann Rheum Dis 2003;55:424-31.
4) Cole BJ, Schumacher HR. Injectable corticosteroids in modern practice. J Am Acad Orthop Surg 2005;13:37-46.
5) Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981;10:231-254.
6) Hollander JL. Intrasynovial corticosteroid therapy in arthritis. Md State Med J 1969;19:62-6.
7) 井尻慎一郎.22万回の関節内注射後の感染率とその対応.日臨整誌2015;40:1-11.
8) Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132.
9) 夏井 睦:創傷治療の常識非常識.東京,三輪書店:2004;pp 38-9.
10) Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med 1985;312:764-71.